The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice

Clinical and Experimental Allergy

Volumn 44, Issue 6, 2014, Pages 867-881

  Dioszeghy, V ^a   Mondoulet, L ^a   Dhelft, V ^a   Ligouis, M ^a   Puteaux, E ^a   Dupont, C ^b   Benhamou, P H ^a  

^a DBV TECHNOLOGIES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Epicutaneous immunotherapy; Peanut allergy; Regulatory T cells

Indexed keywords

EOTAXIN; PEANUT EXTRACT; TRANSCRIPTION FACTOR FOXP3; ALLERGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL ISOLATION; CELL SELECTION; CONTROLLED STUDY; DRUG DELIVERY DEVICE; EOSINOPHILIA; EPICUTANEOUS IMMUNOTHERAPY; ESOPHAGUS; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LYMPHOCYTE COUNT; MOUSE; NEWBORN; NONHUMAN; PEANUT ALLERGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REPORTER GENE; SENSITIZATION; SPLEEN; T CELL DEPLETION; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; ARACHIS; DESENSITIZATION; DISEASE MODEL; DRUG EFFECTS; EOSINOPHILIC ESOPHAGITIS; IMMUNOLOGY; LYMPHOCYTE DEPLETION; METABOLISM; MUCOSA; PATHOLOGY; PEANUT HYPERSENSITIVITY; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; ARACHIS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; FEMALE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE DEPLETION; MICE; MUCOUS MEMBRANE; PEANUT HYPERSENSITIVITY; PHENOTYPE; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84901234714     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12312     Document Type: Article

References (44)

1. Shamji MH, Durham SR. Mechanisms of immunotherapy to aeroallergens. Clin Exp Allergy 2011; 41:1235-46.
2. Ebner C, Siemann U, Bohle B et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997; 27:1007-15.
3. O'Brien RM, Byron KA, Varigos GA, Thomas WR. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes. Clin Exp Allergy 1997; 27:46-51.
4. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120:707-13.
5. Jutel M, Akdis M, Budak F et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-14.
6. Scadding GW, Shamji MH, Jacobson MR et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 2010; 40:598-606.
7. Akdis M, Verhagen J, Taylor A et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199:1567-75.
8. Fujimura T, Yonekura S, Horiguchi S et al. Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Clin Immunol 2011; 139:65-74.
9. Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H, Benhamou PH. Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010; 125:1165-7.
10. Dioszeghy V, Mondoulet L, Dhelft V et al. Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice. J Immunol 2011; 186:5629-37.
11. Mondoulet L, Dioszeghy V, Larcher T et al. Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. PLoS ONE 2012; 7:e31967.
12. Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Dupont C, Benhamou C. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy 2010; 40:659-67.
13. Mondoulet L, Dioszeghy V, Vanoirbeek JA, Nemery B, Dupont C, Dupont C. Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts. Int Arch Allergy Immunol 2011; 154:299-309.
14. Francis JN, James LK, Paraskevopoulos G et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008; 121:1120-5. e2.
15. Mobs C, Slotosch C, Loffler H, Jakob T, Hertl M, Pfutzner W. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. J Immunol 2010; 184:2194-203.
16. Jutel M, Akdis CA. Immunological mechanisms of allergen-specific immunotherapy. Allergy 2011; 66:725-32.
17. + regulatory T cells. J Leukoc Biol 2006; 80:458-70.
18. Wu K, Bi Y, Sun K, Wang C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 2007; 4:269-75.
19. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009;123: 735-46; quiz 47-8.
20. Williams LM, Rudensky AY. Main-tenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007; 8:277-84.
21. Smith M, Tourigny MR, Noakes P, Thornton CA, Tulic MK, Prescott SL. Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+)CD127(lo/-) regulatory T cell function. J Allergy Clin Immunol 2008; 121:1460-6, 1466.e1-7.
22. Krogulska A, Borowiec M, Polakowska E, Dynowski J, Mlynarski W, Wasowska-Krolikowska K. FOXP3, IL-10, and TGF-beta genes expression in children with IgE-dependent food allergy. J Clin Immunol 2011; 31:205-15.
23. + regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004; 199:1679-88.
24. Shreffler WG, Wanich N, Moloney M, Nowak-Wegrzyn A, Sampson HA. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 2009; 123:43-52.e7.
25. Sicherer SH, Wood RA, Stablein D et al. Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol 2010; 125:1077-83.e8.
26. Savilahti EM, Karinen S, Salo HM et al. Combined T regulatory cell and Th2 expression profile identifies children with cow's milk allergy. Clin Immunol 2010; 136:16-20.
27. + T cells regulate the intensity of hypersensitivity responses to peanut, but are not decisive in the induction of oral sensitization. Clin Exp Allergy 2007; 37:572-81.
28. Kanjarawi R, Dercamp C, Etchart N et al. Regulatory T cells control type I food allergy to Beta-lactoglobulin in mice. Int Arch Allergy Immunol 2011; 156:387-96.
29. + T cells during specific venom immunotherapy. Clin Exp Allergy 2008; 38:291-7.
30. Mamessier E, Birnbaum J, Dupuy P, Vervloet D, Magnan A. Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy. Clin Exp Allergy 2006; 36:704-13.
31. Jones SM, Pons L, Roberts JL et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124:292-300, 300.e1-97.
32. + T regulatory cells are not involved in oral desensitization. Int J Immunopathol Pharmacol 2010; 23:359-61.
33. Grindebacke H, Larsson P, Wing K, Rak S, Rudin A. Specific immunotherapy to birch allergen does not enhance suppression of Th2 cells by CD4(+)CD25(+) regulatory T cells during pollen season. J Clin Immunol 2009; 29:752-60.
34. Yamanaka K, Yuta A, Kakeda M et al. Induction of IL-10-producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis. J Allergy Clin Immunol 2009; 124:842-5.e7.
35. + and type 1 regulatory T cells. Curr Top Microbiol Immunol 2005; 293:303-26.
36. Nagato T, Kobayashi H, Yanai M et al. Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells. J Immunol 2007; 178:1189-98.
37. + T cells. J Allergy Clin Immunol 2008; 122:603-9. e5.
38. van Wijk F, Hoeks S, Nierkens S et al. CTLA-4 signaling regulates the intensity of hypersensitivity responses to food antigens, but is not decisive in the induction of sensitization. J Immunol 2005; 174:174-9.
39. + Treg cells. Cell Mol Immunol 2010; 7:414-8.
40. + T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J Immunol 1998; 161:963-70.
41. Sather BD, Treuting P, Perdue N et al. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 2007; 204:1335-47.
42. Tomura M, Honda T, Tanizaki H et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest 2010; 120:883-93.
43. +CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108:4260-7.
44. + regulatory T cells. J Exp Med 2004; 199:303-13.